152 related articles for article (PubMed ID: 3196916)
41. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
42. Neurogenically evoked cerebral artery constriction is mediated by neuropeptide Y.
Laher I; Germann P; Bevan JA
Can J Physiol Pharmacol; 1994 Sep; 72(9):1086-8. PubMed ID: 7842391
[TBL] [Abstract][Full Text] [Related]
43. Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine.
Corr L; Burnstock G; Poole-Wilson P
Peptides; 1993; 14(2):359-64. PubMed ID: 8483814
[TBL] [Abstract][Full Text] [Related]
44. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
45. The permeability change of major cerebral arteries in experimental vasospasm.
Ohta T; Satoh G; Kuroiwa T
Neurosurgery; 1992 Mar; 30(3):331-5; discussion 335-6. PubMed ID: 1620294
[TBL] [Abstract][Full Text] [Related]
46. Localization of neuropeptide Y and norepinephrine in the porcine ovarian artery and their influence on the local blood pressure.
Markiewicz W; Jaroszewski JJ; Barszczewska B; Sienkiewicz W
Folia Histochem Cytobiol; 2003; 41(2):73-81. PubMed ID: 12722792
[TBL] [Abstract][Full Text] [Related]
47. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
48. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm.
Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F
Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224
[TBL] [Abstract][Full Text] [Related]
49. Effect of neuropeptide Y on norepinephrine-induced constriction in the rabbit facial artery after carotid artery occlusion.
Roganović J; Petrović N; Djukić L
Vojnosanit Pregl; 2014 Jun; 71(6):571-5. PubMed ID: 25039112
[TBL] [Abstract][Full Text] [Related]
50. Vasoconstriction of the basilar artery in rabbits: the vasoconstrictor activity of blood, CSF and blood-CSF mixtures incubated for varying periods of time.
Fernandez E; Maira G; Pallini R; Puca A
Neurochirurgia (Stuttg); 1987 Nov; 30(6):168-71. PubMed ID: 3696355
[TBL] [Abstract][Full Text] [Related]
51. Effect of neuropeptide Y on hemodynamics of the rabbit lung.
Lang SA; Maron MB
J Appl Physiol (1985); 1998 Feb; 84(2):618-23. PubMed ID: 9475874
[TBL] [Abstract][Full Text] [Related]
52. Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm.
Seifert V; Stolke D; Kunz U; Resch K
Neurosurgery; 1988 Sep; 23(3):313-21. PubMed ID: 3147407
[TBL] [Abstract][Full Text] [Related]
53. Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage.
Lobato RD; Marín J; Salaices M; Rivilla F; Burgos J
J Neurosurg; 1980 Oct; 53(4):480-5. PubMed ID: 7420169
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology and pathophysiology of cerebral vasospasm following subarachnoid hemorrhage.
Pasqualin A
J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):15-21. PubMed ID: 9800597
[TBL] [Abstract][Full Text] [Related]
55. Different effects of neuropeptide Y on electrically induced contractions in the longitudinal and circular smooth muscle layers of the female rabbit urethra.
Sjögren C; Andersson KE; Andersson PO; Mattiasson A; Uvelius B
Acta Physiol Scand; 1988 Jun; 133(2):177-81. PubMed ID: 2852440
[TBL] [Abstract][Full Text] [Related]
56. Pharmacodynamic evaluation of human cerebral arteries in the genesis of vasospasm.
White RP; Robertson JT
Neurosurgery; 1987 Oct; 21(4):523-31. PubMed ID: 3683786
[TBL] [Abstract][Full Text] [Related]
57. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.
Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T
J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257
[TBL] [Abstract][Full Text] [Related]
58. Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.
Mejia JA; Pernow J; von Holst H; Rudehill A; Lundberg JM
J Neurosurg; 1988 Dec; 69(6):913-8. PubMed ID: 2461438
[TBL] [Abstract][Full Text] [Related]
59. Magnesium inhibits the responses to neuropeptide Y in the rabbit coronary artery.
Corr L; Burnstock G; Poole-Wilson P
J Mol Cell Cardiol; 1991 Mar; 23(3):231-5. PubMed ID: 1880809
[TBL] [Abstract][Full Text] [Related]
60. Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage.
Widenka DC; Medele RJ; Stummer W; Bise K; Steiger HJ
J Neurosurg; 1999 Jun; 90(6):1098-104. PubMed ID: 10350258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
